Measurement of soluble glycoprotein VI in studies of abacavir-based therapy: concerns about test precision.
Sign Up to like & getrecommendations! Published in 2018 at "AIDS"
DOI: 10.1097/qad.0000000000001944
Abstract: In their recent article, O’Halloran et al. [1] describe a statistically significant rise in circulating levels of soluble glycoprotein VI (sGPVI) among individuals switched from abacavir (ABC) to tenofovir disoproxil fumarate (TDF) at 48 weeks… read more here.
Keywords: soluble glycoprotein; measurement soluble; studies abacavir; therapy ... See more keywords